KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Return on Capital Employed (2018 - 2026)

ClearPoint Neuro's Return on Capital Employed history spans 12 years, with the latest figure at 35.39% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 2178.0% to 35.39% in Q4 2025 year-over-year; TTM through Dec 2025 was 35.39%, a 2178.0% decrease, with the full-year FY2025 number at 41.88%, down 2882.0% from a year prior.
  • Return on Capital Employed hit 35.39% in Q4 2025 for ClearPoint Neuro, down from 13.09% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CLPT hit a ceiling of 13.09% in Q3 2025 and a floor of 63.5% in Q1 2024.
  • Historically, Return on Capital Employed has averaged 32.69% across 5 years, with a median of 29.26% in 2022.
  • Biggest five-year swings in Return on Capital Employed: plummeted -2989bps in 2023 and later skyrocketed 4906bps in 2024.
  • Tracing CLPT's Return on Capital Employed over 5 years: stood at 21.44% in 2021, then plummeted by -53bps to 32.78% in 2022, then tumbled by -91bps to 62.67% in 2023, then surged by 78bps to 13.61% in 2024, then tumbled by -160bps to 35.39% in 2025.
  • Business Quant data shows Return on Capital Employed for CLPT at 35.39% in Q4 2025, 13.09% in Q3 2025, and 17.65% in Q2 2025.